Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

Office of Research & Development

print icon sign up for VA Research updates

Funded Project Details - FY2021




Project Number:

I01BX002950-01
Title: Retinal Ganglion Cell Differentiation and Transplantation
Principal Investigator:

Jeffrey Goldberg

Location: Palo Alto, CA
Congressional District Code: 52
Research Service: Biomedical Laboratory R&D
Project Period: January 2017 - December 2020
FY 2021 Funding Amount: $42,000
Total Award Amount
(all years):
$745,500
Abstract: View full abstract and other project information on NIH RePORTER
Go To NIH RePORTER


Excerpt:

Optic nerve degenerations as seen in glaucoma, ischemic and traumatic optic neuropathies, are a leading cause of blindness in the U.S. and worldwide, and are very common in the veteran popuation. They are characterized by loss of retinal ganglion cells (RGCs), which are not replaced by endogenous mechanisms, and thus vision loss is generally irreversible. Cell transplantation therapies provide new hope to protect or even to replace degenerated RGCs and restore visual function. However, little is...



Questions about the R&D website? Email the Web Team.

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.